Pratik Pangaonkar

Senior Manager, KOL Analysis At Neolytica - A Qpharma Company at Neolytica - A QPharma Company

Pratik Pangaonkar, MBS, is a seasoned professional with extensive experience in healthcare analysis and consulting. Currently serving as Senior Manager of KOL Analysis at Neolytica - A QPharma Company since January 2022, Pratik has previously held roles such as Consultant at Molekule Consulting LLC and Senior Medical Analyst at QPharma, Inc. Pratik's career includes significant contributions at GlobalData Healthcare in various capacities, where analytical skills were applied to market research and business development. Educational credentials include a Master's in Bio Sciences from the Keck Graduate Institute of Applied Life Sciences and a Bachelor's in Pharmacy from the University of Mumbai, complemented by diverse internships in supply chain, global trade compliance, and social media marketing.

Location

King of Prussia, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Neolytica - A QPharma Company

A subsidiary of QPharma, Neolytica brings solutions and a portfolio of products that leverage cutting edge technologies like AI and Data Analytics to deliver significant value in strategic and operational aspects of Medical Affairs, Market Access, Commercial Marketing and Commercial Sales. Our offerings portfolio includes: Ti Expert : This technology and consulting solution brings comprehensive access to data about highly qualified and validated medical professionals, including professional spheres of influence, social relationships, and promotional activities. NotifyMe : A Healthcare KOL engagement service with email alerts. An application that enables enterprise-scale social listening and provides actionable alerts on healthcare stakeholders in a desired therapeutic area. Ti Risk : Dependence on Opioid has increased burden on patients, employers, insurers, society, and the health care system. Our product aims to address this by identifying prescribers and patients that are potentially involved in diversion of opioids by following patient journey and prescriber behaviour, along with supplementary secondary research – Real-time and At-risk scoring analysis. For more details, visit - www.neolytica.ai


Industries

Employees

201-500

Links